Aldosterone and myocardial fibrosis in heart failure

Herz

Volumn 25, Issue 3, 2000, Pages 299-306

  Brilla, Christian G ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Aldosterone; Collagen; Heart failure; Myocardial fibrosis; Spironolactone

Indexed keywords

ALDOSTERONE; ALDOSTERONE RECEPTOR; COLLAGEN; CORTICOSTEROID RECEPTOR; NEUROHORMONE; SPIRONOLACTONE;

ARTICLE; DENSITOMETRY; FIBROBLAST; HEART FAILURE; HEART MUSCLE FIBROSIS; HYPERTENSION; OSMOTIC MINIPUMP; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE;

ADULT; ALDOSTERONE; ANIMALS; CARDIOMYOPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROSIS; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIUM; RATS; SPIRONOLACTONE;

EID: 0033935122     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000590050024     Document Type: Article

References (64)

1. Agelli M, Wahl SM. Collagen production by fibroblasts. Methods Enzymol 1988;163:642-56.
2. Bartosova D, Chvapil M, Korecky B, et al. The growth of the muscular and collagenous parts of the rat heart in various forms of cardiomegaly. J Physiol 1969;200:185-95.
3. Beamish RE. Heart failure: the ironic failure of success. Can J Cardiol 1994;10:603.
4. Benetos A, Lacolley P, Safar ME. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1997;17:1152-6.
5. Brilla CG, Funck R, Schencking M, et al. Regression der Myokardfibrose und Verbesserung der diastolischen LV-Funktion bei Patienten mit hypertensiver Herzkrankheit. Z Kardiol 1998;87:Suppl 1:7.abstract.
6. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991;83:1771-9.
7. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991;69:107-15.
8. Brilla CG, Matsubara L, Weber KT. Advanced hypertensive heart disease in spontaneously hypertensive rats: Lisinopril-mediated regression of myocardial fibrosis. Hypertension 1996;28:269-75.
9. Brilla CG, Matsubara LS, Weber KT. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 1993;25:563-75.
10. Brilla CG, Pick R, Tan LB, et al. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990;67: 1355-64.
11. Brilla CG, Reams GP, Maisch B, et al. Renin-angiotensin system and myocardial fibrosis in hypertension: regulation of the myocardial collagen matrix. Eur Heart J 1993;14:Suppl J:57-61.
12. Brilla CG, Weber KT. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res 1992;26:671-7.
13. Brilla CG, Weber KT. Regression of myocardial fibrosis in hypertension by ACE inhibition vs adrenergic blockade. Circulation 1991;84:Suppl 11:11-48.abstract.
14. Brilla CG, Zhou G, Matsubara L, et al. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994;26:809-20.
15. Brilla CG, Zhou G, Myers PR, et al. Angiotensin II-mediated aldosterone synthesis in cultured bovine aortic endothelial cells. J Hypertens 1992;10:Suppl 4:S75, abstract.
16. Brilla CG, Zhou G, Rupp H, et al. Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. Am J Cardiol 1995;76:8D-13D.
17. Campbell SE, Katwa LC. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol 1997;29:1947-58.
18. Capasso JM, Palackal T, Olivetti G, et al. Left ventricular failure induced by long-term hypertension in rats. Circ Res 1990;66:1400-12.
19. Carroll EP, Janicki JS, Pick R, et al. Myocardial stiffness and reparative fibrosis following coronary embolization in the rat. Cardiovasc Res 1989;23:655-61.
20. Caulfield JB, Borg TK. The collagen network of the heart. Lab Invest 1979;40:364-72.
21. Chapman D, Weber KT, Eghbali M. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Circ Res 1990;67:787-94.
22. Chua CC, Diglio CA, Siu BB, et al. Angiotensin II induces TGF-beta 1 production in rat heart endothelial cells. Biochem Biophys Acta 1994;1223:141-7.
23. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
24. Consensus Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;326:1429-35.
25. Doering CW, Jalil JE, Janicki JS, et al. Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res 1988;22:686-95.
26. Eghbali M, Tomek R, Sukhatme VP, et al. Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ Res 1991;69:483-90.
27. Eghbali M, Weber KT. Collagen and the myocardium: fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression. Mol Cell Biochem 1990;96:1-14.
28. Factor SM, Flomenbaum M, Zhao MJ, et al. The effects of acutely increased ventricular cavity pressure on intrinsic myocardial connective tissue. J Am Coll Cardiol 1988;12:1582-9.
29. Factor SM, Robinson TF. Comparative connective tissue structure-function relationships in biologic pumps. Lab Invest 1988;58: 150-6.
30. Harris P. Evolution, cardiac failure, and water metabolism. Presidential address. Adv Myocardiol 1985;5:1-11.
31. Hess OM, Schneider J, Koch R, et al. Diastolic function and myocardial structure in patients with myocardial hypertrophy. Special reference to normalized viscoelastic data. Circulation 1981;63: 360-71.
32. Jalil JE, Doering CW, Janicki JS, et al. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989;64:1041-50.
33. Jalil JE, Janicki JS, Pick R, et al. Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension: Response to captopril. Am J Hypertens 1991;4:51-5.
34. Jalil JE, Janicki JS, Pick R, et al. Fibrosis-induced reduction of endomyocardium in the rat after isoproterenol treatment. Circ Res 1989;65:258-64.
35. Kannel WB, Cobb J. Left ventricular hypertrophy and mortality -results from the Framingham Study. Cardiology 1992;81:291-8.
36. Katwa LC, Weber KT. Aldosterone-induced expression of ET1, ET3 and ETB receptors by cultured adult rat cardiac fibroblasts. Circulation 1996;94:1-46.abstract
37. Komuro I, Kaida T, Shibazaki Y, et al. Stretching cardiac myocytes stimulates protooncogene expression. J Biol Chem 1990;265: 3595-8.
38. Lee AA, Dillmann WH, McCulloch AD, et al. Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 1995;27: 2347-57.
39. Lindy S, Turto H, Uitto J. Protocollagen proline hydroxylase activity in rat heart during experimental cardiac hypertrophy. Circ Res 1972;30:205-9.
40. Mann DL, Kent RL, Cooper G 4th. Load regulation of the properties of adult feline cardiocytes: growth induction by cellular deformation. Circ Res 1989;64:1079-90.
41. Marshall BC, Santana A, Xu OP, et al. Metallo-proteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. J Clin Invest 1993;91:1792-9.
42. Michel JB, Salzmann JL, Ossondo Nlom M, et al. Morphometric analysis of collagen network and plasma perfused capillary bed in the myocardium of rats during evolution of cardiac hypertrophy. Basic Res Cardiol 1986;81:142-54.
43. Miki N, Hamamori Y, Hirata K, et al. Transforming growth factor-beta 1 potentiated alpha 1-adrenergic and stretch-induced c-fos mRNA expression in rat myocardial cells. Circ Res 1994;75: 8-14.
44. Nakagawa M, Terracio L, Carver W, et al. Expression of collagenase and IL-1 alpha in developing rat hearts. Dev Dyn 1992;19587-99.
45. Okada Y, Watanabe S, Nakanishi I, et al. Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett 1988;229:157-60.
46. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 1988;77:721-30.
47. Pearlman ES, Weber KT, Janicki JS, et al. Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab Invest 1982;46:158-64.
48. Pitt B, Zannad F, Remme WJ, et al., for the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
49. Robert V, Silvestre JS, Charlemagne D, et al. Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension 1995;26:971-8.
50. Sigel A, Douglas JA, Eghbali-Webb M. Regulation of mRNA transcripts and DNA synthesis in the rat heart following intravenous injection of transforming growth factor beta1. Mol Cell Biochem 1994;141:145-51.
51. Silvestre JS, Robert V, Hymes C, et al. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 1998;273:4883-91.
52. Staessen J, Lijnen P, Fagard R, et al. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression. J Endocrinol 1981;91:457-65.
53. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
54. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
55. Tyagi SC, Ratajska A, Weber KT. Myocardial matrix metalloproteinase(s): localization and activation. Mol Cell Biochem 1993;126: 49-59.
56. Villarreal FJ, Kim NN, Ungab GD, et al. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993;88:2849-61.
57. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-65.
58. Weber KT, Clark WA, Janicki JS, et al. Physiologic versus pathologic hypertrophy and the pressure-overloaded myocardium. J Cardiovasc Pharmacol 1987;10:Suppl 6:S37-49.
59. Weber KT, Janicki JS, Pick R, et al. Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension. Am J Cardiol 1990;65:1G-7G.
60. Weber KT, Janicki JS, Shroff SG, et al. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res 1988;62:757-65.
61. Weber KT, Pick R, Silver MA, et al. Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation 1990;82:1387-401.
62. Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 1989;13:1637-52.
63. Wong HL, Wahl SM. Inflammation and repair. In: Sporn MB, Roberts AB, eds. Peptide growth factors and their receptors II. New York: Springer, 1991:509-48.
64. Young M, Fullerton M, Dilley R, et al. Mineralocorticoids, Hypertension, and cardiac fibrosis. J Clin Invest 1994;93:2578-83.